Bupa is halting the sale of corporate schemes which include time and cost limits to their cancer cover in what is thought to be an industry first.Cancer treatment costs have risen sharply in recent years and insurers have responded by developing financial benefit caps and time restrictions to limit financial exposure for client businesses. However,…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
